Cryo-Cell International, Inc. (AMEX: CCEL) Stock Competitors & Peer Comparison
See CCEL's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CCEL and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CCEL | $4.16 | -2.35% | 33.1M | -13.70 | -$0.30 | N/A |
| HCA | $419.53 | +4.36% | 91.3B | 14.57 | $28.96 | +0.71% |
| THC | $264.38 | +2.05% | 21.7B | 15.61 | $17.24 | N/A |
| EHC | $120.71 | +0.20% | 12.1B | 20.82 | $5.84 | +0.63% |
| FMS | $22.33 | -0.53% | 12B | 8.39 | $2.66 | +3.87% |
| DVA | $182.00 | +1.08% | 11.7B | 14.30 | $12.80 | N/A |
| UHS | $171.97 | +0.04% | 10.6B | 7.80 | $22.54 | +0.45% |
| ENSG | $172.05 | +0.88% | 10B | 24.89 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $44.49 | +1.87% | 7.1B | 23.59 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
CCEL vs HCA Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, HCA has a market cap of 91.3B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while HCA trades at $419.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas HCA's P/E ratio is 14.57. In terms of profitability, CCEL's ROE is +0.14%, compared to HCA's ROE of -1.13%. Regarding short-term risk, CCEL is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
CCEL vs THC Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, THC has a market cap of 21.7B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while THC trades at $264.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas THC's P/E ratio is 15.61. In terms of profitability, CCEL's ROE is +0.14%, compared to THC's ROE of +0.51%. Regarding short-term risk, CCEL is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
CCEL vs EHC Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while EHC trades at $120.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas EHC's P/E ratio is 20.82. In terms of profitability, CCEL's ROE is +0.14%, compared to EHC's ROE of +0.25%. Regarding short-term risk, CCEL is less volatile compared to EHC. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
CCEL vs FMS Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, FMS has a market cap of 12B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while FMS trades at $22.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas FMS's P/E ratio is 8.39. In terms of profitability, CCEL's ROE is +0.14%, compared to FMS's ROE of +0.07%. Regarding short-term risk, CCEL is less volatile compared to FMS. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
CCEL vs DVA Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, DVA has a market cap of 11.7B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while DVA trades at $182.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas DVA's P/E ratio is 14.30. In terms of profitability, CCEL's ROE is +0.14%, compared to DVA's ROE of -1.24%. Regarding short-term risk, CCEL is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
CCEL vs UHS Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, UHS has a market cap of 10.6B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while UHS trades at $171.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas UHS's P/E ratio is 7.80. In terms of profitability, CCEL's ROE is +0.14%, compared to UHS's ROE of +0.21%. Regarding short-term risk, CCEL is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
CCEL vs ENSG Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while ENSG trades at $172.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas ENSG's P/E ratio is 24.89. In terms of profitability, CCEL's ROE is +0.14%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, CCEL is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
CCEL vs OSH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas OSH's P/E ratio is -17.65. In terms of profitability, CCEL's ROE is +0.14%, compared to OSH's ROE of +4.64%. Regarding short-term risk, CCEL is less volatile compared to OSH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
CCEL vs PACS Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, PACS has a market cap of 7.1B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while PACS trades at $44.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas PACS's P/E ratio is 23.59. In terms of profitability, CCEL's ROE is +0.14%, compared to PACS's ROE of +0.27%. Regarding short-term risk, CCEL is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
CCEL vs CHE Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while CHE trades at $510.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas CHE's P/E ratio is 24.00. In terms of profitability, CCEL's ROE is +0.14%, compared to CHE's ROE of +0.29%. Regarding short-term risk, CCEL is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
CCEL vs HIMS Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while HIMS trades at $27.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas HIMS's P/E ratio is -43.62. In terms of profitability, CCEL's ROE is +0.14%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, CCEL is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
CCEL vs LHCG Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas LHCG's P/E ratio is 82.83. In terms of profitability, CCEL's ROE is +0.14%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, CCEL is less volatile compared to LHCG. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
CCEL vs LFST Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while LFST trades at $13.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas LFST's P/E ratio is 95.05. In terms of profitability, CCEL's ROE is +0.14%, compared to LFST's ROE of +0.03%. Regarding short-term risk, CCEL is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
CCEL vs CON Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while CON trades at $34.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas CON's P/E ratio is 21.50. In terms of profitability, CCEL's ROE is +0.14%, compared to CON's ROE of +0.47%. Regarding short-term risk, CCEL is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check CON's competition here
National HealthCare Corporation (AMEX: NHC)
CCEL vs NHC Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, NHC has a market cap of 3.6B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while NHC trades at $224.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas NHC's P/E ratio is 29.09. In terms of profitability, CCEL's ROE is +0.14%, compared to NHC's ROE of +0.13%. Regarding short-term risk, CCEL is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
CCEL vs OPCH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, OPCH has a market cap of 3.5B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while OPCH trades at $23.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas OPCH's P/E ratio is 13.74. In terms of profitability, CCEL's ROE is +0.14%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, CCEL is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
CCEL vs AMED Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AMED's P/E ratio is 39.30. In terms of profitability, CCEL's ROE is +0.14%, compared to AMED's ROE of +0.11%. Regarding short-term risk, CCEL is less volatile compared to AMED. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
CCEL vs AVAH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AVAH has a market cap of 3.1B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AVAH trades at $13.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AVAH's P/E ratio is 20.62. In terms of profitability, CCEL's ROE is +0.14%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, CCEL is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
CCEL vs BKD Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, BKD has a market cap of 2.9B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while BKD trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas BKD's P/E ratio is -20.94. In terms of profitability, CCEL's ROE is +0.14%, compared to BKD's ROE of +4.06%. Regarding short-term risk, CCEL is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check BKD's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
CCEL vs GRDN Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while GRDN trades at $42.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas GRDN's P/E ratio is 38.03. In terms of profitability, CCEL's ROE is +0.14%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, CCEL is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check GRDN's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
CCEL vs ACHC Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while ACHC trades at $28.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas ACHC's P/E ratio is 14.17. In terms of profitability, CCEL's ROE is +0.14%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, CCEL is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check ACHC's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
CCEL vs ADUS Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while ADUS trades at $117.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas ADUS's P/E ratio is 17.85. In terms of profitability, CCEL's ROE is +0.14%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, CCEL is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
CCEL vs MD Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while MD trades at $27.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas MD's P/E ratio is 12.09. In terms of profitability, CCEL's ROE is +0.14%, compared to MD's ROE of +0.20%. Regarding short-term risk, CCEL is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check MD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
CCEL vs SEM Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas SEM's P/E ratio is 15.43. In terms of profitability, CCEL's ROE is +0.14%, compared to SEM's ROE of +0.08%. Regarding short-term risk, CCEL is less volatile compared to SEM. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
CCEL vs ASTH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while ASTH trades at $38.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas ASTH's P/E ratio is 45.86. In terms of profitability, CCEL's ROE is +0.14%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, CCEL is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check ASTH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
CCEL vs SNDA Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while SNDA trades at $39.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas SNDA's P/E ratio is -6.39. In terms of profitability, CCEL's ROE is +0.14%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, CCEL is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check SNDA's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
CCEL vs SGRY Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, SGRY has a market cap of 1.8B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while SGRY trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas SGRY's P/E ratio is 36.21. In terms of profitability, CCEL's ROE is +0.14%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, CCEL is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
CCEL vs AMEH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AMEH's P/E ratio is 39.25. In terms of profitability, CCEL's ROE is +0.14%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, CCEL is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AMEH's competition here
Ardent Health Inc. (NYSE: ARDT)
CCEL vs ARDT Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while ARDT trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas ARDT's P/E ratio is 8.98. In terms of profitability, CCEL's ROE is +0.14%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, CCEL is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check ARDT's competition here
Agilon Health, Inc. (NYSE: AGL)
CCEL vs AGL Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AGL trades at $94.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AGL's P/E ratio is -6.09. In terms of profitability, CCEL's ROE is +0.14%, compared to AGL's ROE of -1.19%. Regarding short-term risk, CCEL is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AGL's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
CCEL vs HCSG Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while HCSG trades at $21.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas HCSG's P/E ratio is 17.62. In terms of profitability, CCEL's ROE is +0.14%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, CCEL is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check HCSG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
CCEL vs INNV Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while INNV trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas INNV's P/E ratio is -122.56. In terms of profitability, CCEL's ROE is +0.14%, compared to INNV's ROE of -0.01%. Regarding short-term risk, CCEL is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
CCEL vs PNTG Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while PNTG trades at $39.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas PNTG's P/E ratio is 30.00. In terms of profitability, CCEL's ROE is +0.14%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, CCEL is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
CCEL vs NUTX Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, NUTX has a market cap of 1.4B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while NUTX trades at $196.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas NUTX's P/E ratio is 7.82. In terms of profitability, CCEL's ROE is +0.14%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, CCEL is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check NUTX's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
CCEL vs AMN Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AMN trades at $33.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AMN's P/E ratio is 11.41. In terms of profitability, CCEL's ROE is +0.14%, compared to AMN's ROE of +0.15%. Regarding short-term risk, CCEL is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
CCEL vs BKDT Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas BKDT's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, CCEL is similarly volatile compared to BKDT. This indicates similar risk in terms of short-term price fluctuations for CCEL.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
CCEL vs USPH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while USPH trades at $77.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas USPH's P/E ratio is 30.60. In terms of profitability, CCEL's ROE is +0.14%, compared to USPH's ROE of -0.01%. Regarding short-term risk, CCEL is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
CCEL vs TALK Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas TALK's P/E ratio is 774.34. In terms of profitability, CCEL's ROE is +0.14%, compared to TALK's ROE of +0.00%. Regarding short-term risk, CCEL is less volatile compared to TALK. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
CCEL vs GMRS Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, GMRS has a market cap of 707.8M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while GMRS trades at $12.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas GMRS's P/E ratio is 5.82. In terms of profitability, CCEL's ROE is +0.14%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, CCEL is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
CCEL vs EHAB Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas EHAB's P/E ratio is -197.14. In terms of profitability, CCEL's ROE is +0.14%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, CCEL is less volatile compared to EHAB. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
CCEL vs STLN Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, STLN has a market cap of 628.9M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while STLN trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas STLN's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to STLN's ROE of +2.10%. Regarding short-term risk, CCEL is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
CCEL vs TOI Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas TOI's P/E ratio is -14.25. In terms of profitability, CCEL's ROE is +0.14%, compared to TOI's ROE of +2.10%. Regarding short-term risk, CCEL is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
CCEL vs SRTA Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, SRTA has a market cap of 451.7M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while SRTA trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas SRTA's P/E ratio is -24.61. In terms of profitability, CCEL's ROE is +0.14%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, CCEL is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
CCEL vs MCTA Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas MCTA's P/E ratio is 419.36. In terms of profitability, CCEL's ROE is +0.14%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, CCEL is similarly volatile compared to MCTA. This indicates similar risk in terms of short-term price fluctuations for CCEL.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
CCEL vs CYH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, CYH has a market cap of 414.6M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while CYH trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas CYH's P/E ratio is 4.03. In terms of profitability, CCEL's ROE is +0.14%, compared to CYH's ROE of +0.21%. Regarding short-term risk, CCEL is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
CCEL vs AUNA Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AUNA has a market cap of 384.2M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AUNA trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AUNA's P/E ratio is 4.68. In terms of profitability, CCEL's ROE is +0.14%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, CCEL is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
CCEL vs VMD Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, VMD has a market cap of 333.7M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while VMD trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas VMD's P/E ratio is 24.33. In terms of profitability, CCEL's ROE is +0.14%, compared to VMD's ROE of +0.10%. Regarding short-term risk, CCEL is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
CCEL vs CSU Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas CSU's P/E ratio is 0.67. In terms of profitability, CCEL's ROE is +0.14%, compared to CSU's ROE of -0.33%. Regarding short-term risk, CCEL is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
CCEL vs AIRS Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AIRS has a market cap of 184.1M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AIRS trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AIRS's P/E ratio is -87.00. In terms of profitability, CCEL's ROE is +0.14%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, CCEL is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
CCEL vs JYNT Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, JYNT has a market cap of 115.3M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while JYNT trades at $8.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas JYNT's P/E ratio is 80.90. In terms of profitability, CCEL's ROE is +0.14%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, CCEL is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
CCEL vs FVE Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas FVE's P/E ratio is -5.64. In terms of profitability, CCEL's ROE is +0.14%, compared to FVE's ROE of -0.15%. Regarding short-term risk, CCEL is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
CCEL vs KDLYW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas KDLYW's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, CCEL is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
CCEL vs PARK Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, PARK has a market cap of 94.7M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while PARK trades at $20.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas PARK's P/E ratio is 28.35. In terms of profitability, CCEL's ROE is +0.14%, compared to PARK's ROE of -0.18%. Regarding short-term risk, CCEL is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
CCEL vs BTMD Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, BTMD has a market cap of 64M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while BTMD trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas BTMD's P/E ratio is 13.18. In terms of profitability, CCEL's ROE is +0.14%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, CCEL is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
CCEL vs ALR Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas ALR's P/E ratio is -1.11. In terms of profitability, CCEL's ROE is +0.14%, compared to ALR's ROE of -0.15%. Regarding short-term risk, CCEL is less volatile compared to ALR. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
CCEL vs DCGO Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, DCGO has a market cap of 36.5M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while DCGO trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas DCGO's P/E ratio is -0.20. In terms of profitability, CCEL's ROE is +0.14%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, CCEL is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check DCGO's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
CCEL vs IMAC Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas IMAC's P/E ratio is -2.27. In terms of profitability, CCEL's ROE is +0.14%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, CCEL is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
CCEL vs PIII Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, PIII has a market cap of 28.2M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while PIII trades at $8.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas PIII's P/E ratio is -0.26. In terms of profitability, CCEL's ROE is +0.14%, compared to PIII's ROE of +1.61%. Regarding short-term risk, CCEL is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
CCEL vs EUDA Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, EUDA has a market cap of 24.5M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while EUDA trades at $12.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas EUDA's P/E ratio is -24.74. In terms of profitability, CCEL's ROE is +0.14%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, CCEL is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
CCEL vs CANO-WT Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, CCEL is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
CCEL vs AIH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AIH's P/E ratio is -2.78. In terms of profitability, CCEL's ROE is +0.14%, compared to AIH's ROE of +1.16%. Regarding short-term risk, CCEL is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
CCEL vs PIIIW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, PIIIW has a market cap of 14.9M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas PIIIW's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, CCEL is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO)
CCEL vs CANO Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas CANO's P/E ratio is -0.01. In terms of profitability, CCEL's ROE is +0.14%, compared to CANO's ROE of -1.49%. Regarding short-term risk, CCEL is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
CCEL vs FPCG Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas FPCG's P/E ratio is 0.09. In terms of profitability, CCEL's ROE is +0.14%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, CCEL is similarly volatile compared to FPCG. This indicates similar risk in terms of short-term price fluctuations for CCEL.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
CCEL vs AMS Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AMS's P/E ratio is -5.90. In terms of profitability, CCEL's ROE is +0.14%, compared to AMS's ROE of -0.07%. Regarding short-term risk, CCEL is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
CCEL vs FTRP Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas FTRP's P/E ratio is -1.22. In terms of profitability, CCEL's ROE is +0.14%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, CCEL is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
CCEL vs BMGL Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, BMGL has a market cap of 7.3M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while BMGL trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas BMGL's P/E ratio is -0.88. In terms of profitability, CCEL's ROE is +0.14%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, CCEL is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
CCEL vs AIDX Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AIDX has a market cap of 6.9M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AIDX trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AIDX's P/E ratio is -1.06. In terms of profitability, CCEL's ROE is +0.14%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, CCEL is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
CCEL vs MODV Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas MODV's P/E ratio is -0.03. In terms of profitability, CCEL's ROE is +0.14%, compared to MODV's ROE of +1.36%. Regarding short-term risk, CCEL is similarly volatile compared to MODV. This indicates similar risk in terms of short-term price fluctuations for CCEL.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
CCEL vs GBNH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas GBNH's P/E ratio is -0.06. In terms of profitability, CCEL's ROE is +0.14%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, CCEL is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
CCEL vs RHE Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas RHE's P/E ratio is -1.79. In terms of profitability, CCEL's ROE is +0.14%, compared to RHE's ROE of -1.31%. Regarding short-term risk, CCEL is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
CCEL vs RHE-PA Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, CCEL's ROE is +0.14%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, CCEL is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
CCEL vs TOIIW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, CCEL's ROE is +0.14%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, CCEL is similarly volatile compared to TOIIW. This indicates similar risk in terms of short-term price fluctuations for CCEL.Check TOIIW's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
CCEL vs STLNW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, STLNW has a market cap of 4M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while STLNW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas STLNW's P/E ratio is -0.13. In terms of profitability, CCEL's ROE is +0.14%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, CCEL is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
CCEL vs IMACW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas IMACW's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, CCEL is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
CCEL vs EDVA Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, EDVA has a market cap of 1.6M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while EDVA trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas EDVA's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to EDVA's ROE of N/A. Regarding short-term risk, CCEL is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
CCEL vs EUDAW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while EUDAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, CCEL's ROE is +0.14%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, CCEL is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
CCEL vs CCM Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, CCM has a market cap of 605.8K. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while CCM trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas CCM's P/E ratio is -0.28. In terms of profitability, CCEL's ROE is +0.14%, compared to CCM's ROE of +0.06%. Regarding short-term risk, CCEL is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
CCEL vs NIVF Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while NIVF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas NIVF's P/E ratio is 0.56. In terms of profitability, CCEL's ROE is +0.14%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, CCEL is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
CCEL vs NIVFW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, NIVFW has a market cap of 43.2K. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, CCEL's ROE is +0.14%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, CCEL is similarly volatile compared to NIVFW. This indicates similar risk in terms of short-term price fluctuations for CCEL.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
CCEL vs MNDR Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, MNDR has a market cap of 36.9K. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while MNDR trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas MNDR's P/E ratio is -0.04. In terms of profitability, CCEL's ROE is +0.14%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, CCEL is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
CCEL vs TALKW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas TALKW's P/E ratio is 0.00. In terms of profitability, CCEL's ROE is +0.14%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, CCEL is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check TALKW's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
CCEL vs ATIP-WT Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, CCEL is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check ATIP-WT's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
CCEL vs TVTY Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas TVTY's P/E ratio is 19.06. In terms of profitability, CCEL's ROE is +0.14%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, CCEL is less volatile compared to TVTY. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check TVTY's competition here
DocGo Inc. (NASDAQ: DCGOW)
CCEL vs DCGOW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas DCGOW's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, CCEL is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check DCGOW's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
CCEL vs SLHG Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas SLHG's P/E ratio is -1.48. In terms of profitability, CCEL's ROE is +0.14%, compared to SLHG's ROE of N/A. Regarding short-term risk, CCEL is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check SLHG's competition here
New Frontier Health Corporation (NYSE: NFH)
CCEL vs NFH Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, NFH has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas NFH's P/E ratio is -19.75. In terms of profitability, CCEL's ROE is +0.14%, compared to NFH's ROE of -0.06%. Regarding short-term risk, CCEL is less volatile compared to NFH. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
CCEL vs SLHGP Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, CCEL's ROE is +0.14%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, CCEL is similarly volatile compared to SLHGP. This indicates similar risk in terms of short-term price fluctuations for CCEL.Check SLHGP's competition here
Almost Family Inc. (NASDAQ: AFAM)
CCEL vs AFAM Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas AFAM's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, CCEL is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
CCEL vs TLMD Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas TLMD's P/E ratio is -1.60. In terms of profitability, CCEL's ROE is +0.14%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, CCEL is less volatile compared to TLMD. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
CCEL vs KND Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, KND has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas KND's P/E ratio is -1.14. In terms of profitability, CCEL's ROE is +0.14%, compared to KND's ROE of -0.53%. Regarding short-term risk, CCEL is less volatile compared to KND. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check KND's competition here
Hanger, Inc. (NYSE: HNGR)
CCEL vs HNGR Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas HNGR's P/E ratio is 19.71. In terms of profitability, CCEL's ROE is +0.14%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, CCEL is less volatile compared to HNGR. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check HNGR's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
CCEL vs DVCR Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas DVCR's P/E ratio is 28.34. In terms of profitability, CCEL's ROE is +0.14%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, CCEL is less volatile compared to DVCR. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check DVCR's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
CCEL vs TLMDW Comparison September 2026
Cryo-Cell International, Inc. (AMEX: CCEL) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCEL stands at 33.1M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, CCEL is priced at $4.16 on the AMEX, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCEL currently has a P/E ratio of -13.70, whereas TLMDW's P/E ratio is N/A. In terms of profitability, CCEL's ROE is +0.14%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, CCEL is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for CCEL.Check TLMDW's competition here